Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients.

Keiji HiraiMasako ShimotashiroTokio SonodaToshiaki OkumuraSusumu OokawaraYoshiyuki Morishita

Published in: Clinical and experimental nephrology (2022)

Autoimmune disease presence, lymphocyte counts, hemoglobin levels, and blood urea nitrogen concentrations were associated with the anti-SARS-CoV-2 spike antibody titer after the second dose of the BNT162b2 messenger RNA COVID-19 vaccine in Japanese patients undergoing hemodialysis.

Keyphrases

sars cov
patients undergoing
respiratory syndrome coronavirus
peripheral blood
coronavirus disease
chronic kidney disease
peritoneal dialysis
end stage renal disease